Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces.
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The plasma protein factor H primarily controls the activation of the alternative pathway of complement. The C-terminal of factor H is known to be involved in protection of host cells from complement attack. In the present study, we show that domains 19–20 alone are capable of discriminating between host-like and complement-activating cells. Furthermore, although factor H possesses three binding sites for C3b, binding to cell-bound C3b can be almost completely inhibited by the single site located in domains 19–20. All of the regulatory activities of factor H are expressed by the N-terminal four domains, but these activities toward cell-bound C3b are inhibited by isolated recombinant domains 19–20 (rH 19–20). Direct competition with the N-terminal site is unlikely to explain this because regulation of fluid phase C3b is unaffected by domains 19–20. Finally, we show that addition of isolated rH 19–20 to normal human serum leads to aggressive complement-mediated lysis of normally nonactivating sheep erythrocytes and moderate lysis of human erythrocytes, which possess membrane-bound regulators of complement. Taken together, the results highlight the importance of the cell surface protective functions exhibited by factor H compared with other complement regulatory proteins. The results may also explain why atypical hemolytic uremic syndrome patients with mutations affecting domains 19–20 can maintain complement homeostasis in plasma while their complement system attacks erythrocytes, platelets, endothelial cells, and kidney tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, M. pneumoniae can bind factor H through specific binding proteins, such as EF-Tu, PDH-B, and PDH-A, thereby mimicking host cells to regulate complement activation and evade immune responses (Ferreira et al., 2006; Yu et al., 2020).”
From Advances in adhesion-related pathogenesis in Mycoplasma pneumoniae infection (2025) · cites this paper as Ferreira et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
Research works printed but not linked: 70
- 2001, J. Am. Soc. Nephrol., 297
- 2000, Am. J. Hum. Genet., 1721
- 2004, J. Am. Soc. Nephrol., 787
- 2003, J. Clin. Invest., 1181
- 1994, Am. J. Kidney Dis., 936
- 2001, Am. J. Hum. Genet., 485
- 2004, Mol. Immunol., 355
- 1998, Kidney Int., 836
- 1999, Am. J. Hum. Genet., 1538
- 1999, Mol. Immunol., 241
- 2006, Hum. Mutat., 292
- 2005, Ann. NY Acad. Sci., 144
- 2005, Hum. Mol. Genet., 703
- 2001, Am. J. Hum. Genet., 478
- 2002, J. Mol. Biol., 217
- 2006, J. Biol. Chem., 16512
- 2006, EMBO J., 1784
- 2005, Am. J. Pathol., 1173
- 2002, Nat. Genet., 424
- 2000, J. Immunol., 6075
- 2002, Br. J. Cancer, 1119
- 1998, J. Immunol., 3342
- 1987, Infect. Immun., 174
- 2005, J. Infect. Dis., 1996
- 1998, J. Exp. Med., 743
- 1992, FEMS Microb. Lett., 287
- 1992, Infect. Immun., 39
- 1995, J. Clin. Invest., 1054
- 1986, Proc. Natl. Acad. Sci. USA, 3963
- 1988, Biochem. J., 593
- 1992, J. Immunol., 2592
- 1989, J. Biol. Chem., 20576
- 1984, Biochem. J., 389
- 1996, J. Immunol., 5422
- 1995, J. Immunol., 348
- 1995, J. Immunol., 5663
- 1990, Proc. Natl. Acad. Sci. USA, 3982
- 2006, Mol. Immunol., 1624
- 1991, J. Biol. Chem., 16847
- 1996, Proc. Natl. Acad. Sci. USA, 10996
- 1996, FEBS Lett., 297
- 2000, J. Biol. Chem., 27657
- 2004, Mol. Immunol., 291
- 1996, Eur. J. Immunol., 2383
- 1977, J. Exp. Med., 257
- 1998, Biochem. J., 41
- 1978, Proc. Natl. Acad. Sci. USA, 1971
- 1978, Proc. Natl. Acad. Sci. USA, 2416
- 2005, Science, 421
- 2005, Science, 419
- 2005, Science, 385
- 2005, Proc. Natl. Acad. Sci. USA, 7227
- 1981, J. Biol. Chem., 3995
- 1987, J. Immunol. Methods, 7
- 1971, J. Exp. Med., 90s
- 1979, J. Immunol., 529
- 1983, Methods Enzymol., 278
- 1998, J. Biol. Chem., 16828
- 1982, J. Immunol., 2603
- 1983, Proc. Natl. Acad. Sci. USA, 5430
- 1977, J. Exp. Med., 22
- 2000, J. Immunol., 4742
- 1991, Transfus. Med. Rev., 123
- 1998, Complement Regulatory Proteins, 32
- 2000, J. Biol. Chem., 12917
- 2005, Clin. Chem., 856
- 1987, Mol. Immunol., 487
- 2006, Clin. Exp. Immunol., 342
- 2001, Kidney Int., 831
- 2006, J. Mol. Med., 378
Cited by
Complement control protein factor H: The good, the bad, and the inadequate
Ferreira, V. P., Pangburn, M. K., & Cortés, C. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.05.007 · Cited by 420
Self-citationComplement activation, regulation, and molecular basis for complement‐related diseases
Bajic, G., Degn, S. E., Thiel, S., & Andersen, G. R. (2015) · The EMBO Journal · doi:10.15252/embj.201591881 · Cited by 374
Structural basis for sialic acid–mediated self-recognition by complement factor H
Blaum, B. S., Hannan, J. P., Herbert, A. P., Kavanagh, D., Uhrín, D., & Stehle, T. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1696 · Cited by 278
Self-citationFactor H family proteins and human diseases
Józsi, M., & Zipfel, P. F. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.04.008 · Cited by 254
Complement in removal of the dead – balancing inflammation
Martin, M., & Blom, A. M. (2016) · Immunological Reviews · doi:10.1111/imr.12462 · Cited by 130
Metadata
- Authors
- Ferreira, V. P., Herbert, A. P., Hocking, H. G., Barlow, P. N., & Pangburn, M. K.
- Affiliations
- Department of Biochemistry, Center for Biomedical Research, University of Texas, Health Science Center , Tyler, TX 75708
- Edinburgh Biomolecular Nuclear Magnetic Resonance Unit, University of Edinburgh , Edinburgh ,
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-11-01
- Volume
- 177
- Issue
- 9
- Pages
- 6308-6316
- ISSN
- 0022-1767
- 1550-6606
- Cited by
- 131
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. https://app.cochat.ai/papers/10.4049/jimmunol.177.9.6308
- The paper
- Ferreira, V. P., Herbert, A. P., Hocking, H. G., Barlow, P. N., & Pangburn, M. K. (2006). Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. The Journal of Immunology. https://doi.org/10.4049/jimmunol.177.9.6308
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.